CRA II: Sponsor-Dedicated (Paris)

Syneos Health, Inc.; Paris; Hybrid; EUR 50,000 - 65,000; Full time

Job summary

Syneos Health, Inc. is seeking a CRA II based in the Paris area to perform site qualification, initiation, interim monitoring and close-out visits, ensuring GCP and regulatory compliance.

The role involves on-site or remote work, data verification, IP handling, and collaboration with sponsor teams. You should have a bachelor’s degree or nursing background, strong communication, and the ability to travel up to 75% regularly.

Qualifications

• Knowledge of ICH/GCP guidelines and other regulatory requirements.
• Bachelor’s degree or RN in a related field or equivalent.
• Excellent communication and interpersonal skills.
• Able to travel up to 75% on a regular basis.

Responsibilities

• Perform site qualification, initiation, interim monitoring, and close-out visits (on-site or remote).
• Ensure regulatory, ICH-GCP and GPP compliance and document site performance.
• Verify informed consent, protection of subject confidentiality, and data integrity.
• Conduct source data verification and query resolution, both remotely and on site.
• Manage IP inventory, labeling, and handling per protocol; ensure archiving and TMF alignment.
• Prepare for Investigator Meetings and sponsor/clinical training sessions; support audit readiness.
• Collaborate with sponsor affiliates and local staff; train junior team members as needed.

Skills

Excellent communication

Interpersonal skills

Presentation skills

Good computer skills

Adapt to new technologies

Travel readiness

Education

Bachelor’s degree or RN in related field

Job description

Syneos Health, Inc. is seeking a CRA II based in the Paris area to perform site qualification, initiation, interim monitoring and close-out visits, ensuring GCP and regulatory compliance.

The role involves on-site or remote work, data verification, IP handling, and collaboration with sponsor teams. You should have a bachelor’s degree or nursing background, strong communication, and the ability to travel up to 75% regularly.